Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2000
09/27/2000CN1268125A Dicyclanil Polymorphs and hydrates and their preparation
09/27/2000CN1268124A Derivatives of acyl-piperazinil-pyrimidins, preparation thereof and application as medicaments
09/27/2000CN1268123A Benzimidazole derivatives
09/27/2000CN1268122A Branched alkoxy- substituted 2-aminopyridines as NOS inhibitors
09/27/2000CN1268121A Crystalline 10,10-bis ((2-fluoro-4-pyridinyl) methyl)-9 (10H)-anthraclnone and an improved process for preparing the same
09/27/2000CN1268120A Novel dihydronaphthalene compound and process and producing the same
09/27/2000CN1268112A Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives
09/27/2000CN1268061A Combination of tyrosine kinase inhibitor and chemical castration to treat prostate cancer
09/27/2000CN1268060A Sustained-release oral preparation
09/27/2000CN1268056A Use of uridine 5'-diphosphate and analogs thereof for the treatment of lung diseases
09/27/2000CN1268055A Pharmaceutical suspension comprising nevirapine hemihydrate
09/27/2000CN1268054A Combination therapy comprising amlodipine and a statin compound
09/27/2000CN1268053A Combination therapy comprising atorvastatin and an antihypertensive agent
09/27/2000CN1268052A Therapeutic combinations comprising amlodipin and atorvastatin
09/27/2000CN1268051A Clear, injectable formulation of an anesthetic compound
09/27/2000CN1268050A Pharmaceutical composition for combination of piperidinoalkanol-decongestant
09/27/2000CN1267670A Two aporphine-benzyl isoquinoline compounds with antineoplastic activity
09/27/2000CN1267665A Preparation of notoginseng essence as efficient hemostatic material
09/27/2000CN1267548A Sleep regulating composition prepared with melatonin and diazepam
09/27/2000CN1267546A Medicine for rheumatism and its preparation
09/27/2000CN1267545A Medicine for injury pain and its preparation
09/27/2000CN1267543A Quick-healing burn and scald treating medicine powder
09/27/2000CN1267519A Immune regulator, immune regulator food and immune regulator fodder
09/27/2000CN1267518A Notoginseng total saponin capsule and its preparation
09/27/2000CN1267517A Hernia treating medicine
09/27/2000CN1267507A Composition containing L-2-keto thiazolidine-4-carboxylic acid in continuous aqueous phase
09/27/2000CN1056883C Process for producing avermectins B and cultures therefor
09/27/2000CN1056849C Fungistatin derivate and its preparing method and its application in pharmacy
09/27/2000CN1056847C 7-acyl-3-(substd. carbamoyloxy) cephem compounds and their preparation process
09/27/2000CN1056846C Spiro-azabicyclic compounds useful in therapy
09/27/2000CN1056844C Dioxide pyrrolo-pyrrolo derivatives
09/27/2000CN1056837C 5-arylisoxazol-4-yl-substituted 2-aminocarboxylic acid compound, its medical composition and use
09/27/2000CN1056836C 3,5-disubstituted and 3,4,5-trisubstituted 2-isoxazolines and isoxazoles and producing process thereof and their use as medicaments
09/27/2000CN1056835C Novel selective aromatase inhibiting compounds
09/27/2000CN1056832C Fused dihydropyridine derivate, its producing process, and its pharmaceutical composition
09/27/2000CN1056824C Improved synthesis of cyclopropylacetylene
09/27/2000CN1056765C Tranquillizer composition for treating chronic nervous disease
09/27/2000CN1056748C Application of rhizoma bolbostemmae glucoside for preparing medicine to treat leukaemia
09/27/2000CN1056747C Diagnosis and treatment of virus infections associated with chronic fatigue
09/26/2000US6124494 Anti-viral compounds
09/26/2000US6124464 Mixing a substituted sulfinyl heterocyclic compound containing an imidazole moiety with an alkylamine base or ammonia and a magnesium salt.
09/26/2000US6124461 Compounds, compositions, and methods for treating erectile dysfunction
09/26/2000US6124460 Isoquinuclidine derivatives, method of manufacturing the same and therapeutic agents for hypercholesterolemia containing these compounds
09/26/2000US6124457 Process and intermediates for a β3 -adrenergic receptor agonist
09/26/2000US6124456 Adenosine antagonists
09/26/2000US6124455 Aryl or heteroaryl amides of tetrahydronaphthalene, chroman, thiochroman and 1,2,3,4-tetrahydroquinoline carboxylic acids, having an electron withdrawing substituent in the aromatic or heteroaromatic moiety, having retinoid-like biological activity
09/26/2000US6124450 Processes and intermediates for phosphorous-containing covalent linkages
09/26/2000US6124445 Phosphotriester oligonucleotides, amidities and method of preparation
09/26/2000US6124433 Polypeptide for use in the detection and monitoring of atherosclerosis, ischemia, hypertension, restenosis, and arterial inflammation
09/26/2000US6124364 Topically applying thereto, for such period of time as required to elicit the desired response, a therapeutically effective amount of at least one hydroxystilbene
09/26/2000US6124363 Dofetilide polymorphs
09/26/2000US6124362 Topical administration of lupane triterpenes, derivatives of lupane triterpenes, derivatives of oleanane triterpenes, derivatives of ursane triterpenes, and salts
09/26/2000US6124360 Solid compositions suitable for oral administration comprising non hygroscopic salts of L-carnitine and alkanoyl-L-carnitine with 2-aminoethanesulfonic acid
09/26/2000US6124358 Pharmaceutical composition containing rhein or diacerhein with improved bioavailability
09/26/2000US6124355 Oxybutynin therapy
09/26/2000US6124354 Arylcycloalkane carboxylic esters, their use, pharmaceutical compositions and preparation
09/26/2000US6124353 Method of treating ocular hypertension with 8-epi prostaglandins
09/26/2000US6124352 Antifungal agents
09/26/2000US6124349 Contacting mixture of carbon disulfide, secondary amine and a pharmaceutically acceptable methanol-free diluent in mixing zone under inert gas atmosphere, wherein diluent is solvent for carbon disulfide, but not for dithiocarbamate, cooling
09/26/2000US6124348 Vitamin C skin formulations
09/26/2000US6124347 Have inhibitory action against the formation of advanced glycation end-products and are useful as pharmaceuticals for the prevention and treatment of various adult diseases, especially diabetic complications
09/26/2000US6124346 Estrogen agonist/antagonists treatment of atherosclerosis
09/26/2000US6124344 Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
09/26/2000US6124342 Pharmaceutical compositions containing pyrylium compounds, pyrylium salts and process for manufacturing a medicament containing the aforesaid compounds
09/26/2000US6124338 Treating migraine headache
09/26/2000US6124337 Treating male impotence by orally ingesting a mixture comprising a disintegrant to accelerate dissolution a phentolamine vasodilator effective within one hour prior to attempting sexual intercourse
09/26/2000US6124332 Metalloproteinase inhibitors
09/26/2000US6124330 N-[4-(Heteroarylmethyl)phenyl]-heteroarylamines
09/26/2000US6124329 Metalloproteinase inhibitors
09/26/2000US6124328 Methods and compositions for stimulating neurite growth
09/26/2000US6124326 Use of flupirtine for the prophylaxis and therapy of disorders which are associated with an unphysiologically high cell death rate
09/26/2000US6124325 Triazole antifungal agents
09/26/2000US6124324 An enzyme inhibitor of reverse transcriptase for the treatment of hiv infection, including mutant, drug-sensitive, drug-resistant, and multi-drug resistant strains of hiv
09/26/2000US6124322 An aqueous thalidomide solution comprising a pure enantiomer of thalidomide dissolved in an isotonic glucose solution
09/26/2000US6124321 An enzyme inhibitor for enhancing memory or treating or preventing alzheimer's disease
09/26/2000US6124320 Treating with non-sedating antihistamines without causing cardiac arrhythmias
09/26/2000US6124319 3,3-disubstituted piperidines as modulators of chemokine receptor activity
09/26/2000US6124318 A neurotrophic drug treating or preventing a disease involving neuronal degeneration such as senile dementia of the alzheimer type
09/26/2000US6124317 2-substituted piperidine analogs and their use as subtype-selective NMDA receptor antagonists
09/26/2000US6124316 Compounds which are specific antagonists of the human NK3 receptor and their use as medicinal products and diagnostic tools
09/26/2000US6124315 Method for potentiating primary drugs in treating multidrug resistant disease
09/26/2000US6124314 Osteoporosis compounds
09/26/2000US6124313 Imidazopyridine azolidinones
09/26/2000US6124312 Heterocyclic compounds
09/26/2000US6124311 Administering oncolytic agent with enhanced multidrug resistance reversing amount of specified compound
09/26/2000US6124310 Enediyne compounds
09/26/2000US6124309 Method and pharmaceutical composition for regulating lipid concentration
09/26/2000US6124308 Optically active phenyl pyrimidine derivatives as analgesic agent
09/26/2000US6124307 Nonnucleoside inhibitors of reverse transcriptase, composite binding pocket and methods for use thereof
09/26/2000US6124306 Treating human immunodeficiency virus infections
09/26/2000US6124304 Penciclovir for the treatment of zoster associated pain
09/26/2000US6124303 Method for inhibiting neoplastic cells and related conditions by exposure to 9-substituted 2-(2-N-aloxyphenyl) purin-6-ones
09/26/2000US6124300 Treating anxiety or depression
09/26/2000US6124299 Calcitonin mimetics
09/26/2000US6124296 Arylglycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds
09/26/2000US6124294 Compounds having high affinity for dopamine d3 receptor; used to treat disorders which respond to dopamine d3 ligands
09/26/2000US6124293 Semi-synthetic ecteinascidins
09/26/2000US6124292 Antitumor agents
09/26/2000US6124290 Treating bacterial infections
09/26/2000US6124289 Azolo triazines and pyrimidines
1 ... 6240 6241 6242 6243 6244 6245 6246 6247 6248 6249 6250 6251 6252 6253 6254 6255 6256 6257 6258 6259 6260 ... 7860